
No More Tears
- 《紐約時報》暢銷書 · 上榜 2 週
聯盟連結:透過此連結購買即支持 BookRank,價格不變。
關於本書
"He struck up a conversation with the woman on the barstool next to him, who happened to be a drug sales rep for Johnson & Johnson. Her horrific story about unethical sales practices and the devastating impact they’d had on her family fundamentally changed the nature of how Harris would cover the company—and the entire pharmaceutical industry—for the Times. His subsequent investigations and ongoing research since that very first conversation led to this book—a blistering exposé of a trusted American institution and the largest healthcare conglomerate in the world. Harris takes us light-years away from the company’s image as the child-friendly “baby company” as he uncovers reams of evidence showing decades of deceitful and dangerous corporate practices that have threatened the lives of millions. He covers multiple disasters: lies and cover-ups regarding the link of Johnson’s Baby Powder to cancer, the surprising dangers of Tylenol, a criminal campaign to sell antipsychotics that have cost countless lives, a popular drug used to support cancer patients that actually increases the risk that cancer tumors will grow, and deceptive marketing that accelerated opioid addictions through their product Duragesic (fentanyl) that rival even those of the Sacklers and Purdue Pharma. Filled with shocking and infuriating but utterly necessary revelations, No More Tears is a landmark work of investigative journalism that lays bare the deeply rooted corruption behind the image of babies bathi
分數的組成
各來源在 22 則評分上的均值是 8.5。數量還不多,讀者票只占權重的 11%,其餘被拉向排行榜的均值 7.8。7.9 就是這麼來的。
| 來源 | 平均 | 評分數 | 權重 |
|---|---|---|---|
| Hardcover | 8.5 | 22 | 100% |
常見問題
《No More Tears》的評分是多少?
10 分制下 7.9 分,來自 1 個獨立來源的 22 則讀者評分。
No More Tears值得讀嗎?
開放資料中22位讀者給出7.9/10。
《No More Tears》上過暢銷書榜嗎?
上過——在《紐約時報》榜單上 2 週,最高第 14 名。銷量只作展示,從不計入分數。